OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 75 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,140,244 | +91.3% | 1,873,704 | +39.9% | 2.54% | +203.6% |
| Q2 2023 | $12,093,617 | +106.3% | 1,339,271 | -20.7% | 0.84% | +105.2% |
| Q1 2023 | $5,862,617 | +141543.3% | 1,689,515 | 0.0% | 0.41% | -14.7% |
| Q4 2022 | $4,139 | -99.9% | 1,689,515 | 0.0% | 0.48% | -7.4% |
| Q3 2022 | $4,663,000 | -32.2% | 1,689,515 | 0.0% | 0.52% | -25.4% |
| Q2 2022 | $6,876,000 | -4.5% | 1,689,515 | 0.0% | 0.69% | +39.1% |
| Q1 2022 | $7,197,000 | -54.5% | 1,689,515 | 0.0% | 0.50% | -48.0% |
| Q4 2021 | $15,814,000 | -53.7% | 1,689,515 | +36.4% | 0.95% | -37.8% |
| Q3 2021 | $34,135,000 | -1.5% | 1,238,575 | 0.0% | 1.53% | +2.2% |
| Q2 2021 | $34,655,000 | -15.7% | 1,238,575 | 0.0% | 1.50% | +3.9% |
| Q1 2021 | $41,096,000 | -31.0% | 1,238,575 | 0.0% | 1.44% | -45.7% |
| Q4 2020 | $59,551,000 | – | 1,238,575 | – | 2.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |